Clinical Trial Update: Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain [Phase 2]

View source ↗

Summary

This document notes the withdrawal of a Phase 2 trial evaluating a compliance marker in prescription opioid abusers with chronic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Snippet

Sponsor: Georgetown University | Conditions: Compliance, Chronic Pain | Phase 2 | Status: WITHDRAWN